Concepedia

Author

Shunsuke Nagao

Chugai Pharma (United States)ORCID

Also Known As

S Nagao, S. Nagao, SHUNSUKE NAGAO, Shunsuke Nagao

14

Publications

863

Citations

12

H-Index

36

Concepts

All Affiliations

Chugai Pharma (United States)Tokyo Metropolitan Institute of Medical ScienceThe University of TokyoSophia University
SN

About

Shunsuke Nagao is an author at Chugai Pharma (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

95

2

Biochemistry

4

4

79

3

Natural Sciences

2

2

56

4

Health Sciences

1

1

12

5

Biomolecular Engineering

1

1

16

Shunsuke Nagao

×

12

Publications

592

Citations

11

H-Index

YearCitations

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist

Takahiro Kawai, Bingfa Sun, Hitoshi Yoshino,

Proceedings of the National Academy of Sciences

2020

172

Autolytic Transition of μCalpain upon Activation as Resolved by Antibodies Distinguishing between the Pre- and Post-Autolysis Forms1

Takaomi C. Saido, Shunsuke Nagao, Mikiro Shiramine,

The Journal of Biochemistry

1992

144

Distinct kinetics of subunit autolysis in mammalian m‐calpain activation

Takaomi C. Saido, Shunsuke Nagao, Mikiro Shiramine,

FEBS Letters

1994

66

EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease–mineral bone disorder

Yoshinori Tsuboi, Shuichi Ohtomo, Yasuhiro Ichida,

Kidney International

2020

41

Calpain-Calpastatin Interactions in Epidermoid Carcinoma KB Cells1

Shunsuke Nagao, Takaomi C. Saido, Yoshiko Akita,

The Journal of Biochemistry

1994

38

The Novel Formulation Design of Self-emulsifying Drug Delivery Systems (SEDDS) Type O/W Microemulsion I: Enhancing Effects on Oral Bioavailability of Poorly Water Soluble Compounds in Rats and Beagle Dogs

Hiroshi Araya, Shunsuke Nagao, Mikio Tomita,

Drug Metabolism and Pharmacokinetics

2005

37

<i>In vitro</i>profiling of the metabolism and drug–drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes, and recombinant human CYP

Mizuki Yamane, Kosuke Kawashima, Koji Yamaguchi,

Xenobiotica

2014

24

Synthesis and biological activities of a pH-dependently activated water-soluble prodrug of a novel hexacyclic camptothecin analog

Jun Ohwada, Sawako Ozawa, Masami Kohchi,

Bioorganic & Medicinal Chemistry Letters

2009

18

A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts

Mika Endo, Masanori Miwa, Masako Ura,

Cancer Chemotherapy and Pharmacology

2009

16

A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes

T Mitsui, Takayuki Nemoto, Taiji Miyake,

Drug Metabolism and Disposition

2014

13

Page 1